These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3816923)

  • 1. Comparison of a controlled-release tablet of salbutamol given twice daily with a standard tablet given four times daily in the management of chronic obstructive lung disease.
    Maesen FP; Smeets JJ
    Eur J Clin Pharmacol; 1986; 31(4):431-6. PubMed ID: 3816923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pharmacological study of a novel controlled release preparation of salbutamol.
    Milroy R; Carter R; Carlyle D; Boyd G
    Br J Clin Pharmacol; 1990 May; 29(5):578-80. PubMed ID: 2190630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Salmeterol improves the control of disease in patients with moderate asthma. A comparative study of inhaled salmeterol 50 mg and salbutamol depot tablets 8 mg, both administered twice daily].
    Ringbaek TJ; Søes-Petersen U; Christensen M; Iversen ET; Rasmussen FV
    Ugeskr Laeger; 1996 Jul; 158(27):3940-3. PubMed ID: 8701511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salbutamol in treatment of bronchial asthma--comparison of controlled release tablet with standard tablet.
    Wang CR; Yeh TS; Chuang CY; Chen CY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1993 Aug; 26(3):132-7. PubMed ID: 7982368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy, tolerability and patient acceptability of once-daily bambuterol tablets against twice-daily controlled release salbutamol in nocturnal asthma. ACROBATICS Research Group.
    Gunn SD; Ayres JG; McConchie SM
    Eur J Clin Pharmacol; 1995; 48(1):23-8. PubMed ID: 7621843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled release salbutamol tablets versus sustained release theophylline tablets in the control of reversible obstructive airways disease.
    Vyse T; Cochrane GM
    J Int Med Res; 1989; 17(1):93-8. PubMed ID: 2651178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of salbutamol after an oral slow-release preparation.
    Maconochie JG; Fowler P
    Curr Med Res Opin; 1983; 8(9):634-9. PubMed ID: 6667627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the clinical and bronchodilating effects of plain and slow-release tablets of terbutaline at steady state.
    Pauwels R; Elinck W; Lamont H; van der Straeten M; Ljungholm K
    Br J Clin Pharmacol; 1986 Feb; 21(2):217-22. PubMed ID: 3513810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow-release oral salbutamol and aminophylline in nocturnal asthma: relation of overnight changes in lung function and plasma drug levels.
    Fairfax AJ; McNabb WR; Davies HJ; Spiro SG
    Thorax; 1980 Jul; 35(7):526-30. PubMed ID: 7001670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative bioavailability of a controlled-release albuterol formulation for twice-daily use.
    Sykes RS; Reese ME; Meyer MC; Chubb JM
    Biopharm Drug Dispos; 1988; 9(6):551-6. PubMed ID: 3228576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative biologic availability and pharmacokinetics of albuterol preparations in healthy Chinese.
    Yuan Y; Li K; Zhao F
    Ther Drug Monit; 1998 Dec; 20(6):624-7. PubMed ID: 9853977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
    Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single dose absorption profiles and bioavailability of two different salbutamol tablets.
    Jonkman JH; Freie HM; van der Boon WJ; Grasmeijer G
    Arzneimittelforschung; 1986 Jul; 36(7):1133-5. PubMed ID: 3768084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative steady state bioavailability of conventional and controlled-release formulations of albuterol.
    Powell ML; Weisberger M; Dowdy Y; Gural R; Symchowicz S; Patrick JE
    Biopharm Drug Dispos; 1987; 8(5):461-8. PubMed ID: 3663882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of sustained-release terbutaline with ordinary salbutamol in bronchial asthma.
    Beskow R; Ericsson CH; Grönneberg R; Sjögren I; Skedinger M
    Eur J Respir Dis; 1984 Oct; 65(7):509-11. PubMed ID: 6386512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of once-daily Uniphyl tablets compared with twice-daily Theo-Dur tablets in elderly patients with chronic airflow obstruction.
    Rivington RN; Calcutt L; Hodder RV; Stewart JH; Aitken TL
    Am J Med; 1988 Jul; 85(1B):48-53. PubMed ID: 3041826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term, double-blind comparison of controlled-release albuterol versus sustained-release theophylline in adolescents and adults with asthma.
    Pierson WE; LaForce CF; Bell TD; MacCosbe PE; Sykes RS; Tinkelman D
    J Allergy Clin Immunol; 1990 Mar; 85(3):618-26. PubMed ID: 2179367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose and steady-state effects of controlled-release salbutamol on drug level and airflow obstruction in patients with asthma.
    Tan WC; Chan TB; Ang SM
    Singapore Med J; 1992 Aug; 33(4):371-4. PubMed ID: 1411667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Delayed-release salbutamol, a new beta-mimetic with prolonged action. Results of a comparative study against theophylline L.A].
    Brune J; Desfougères JL
    Allerg Immunol (Paris); 1991 Oct; 23(8):358-64. PubMed ID: 1777051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of controlled-release salbutamol in predominantly non-reversible chronic airflow obstruction.
    Mohammed AF; Anderson K; Matusiewicz SP; Boyd G; Greening AP; Thomson NC
    Respir Med; 1991 Nov; 85(6):495-500. PubMed ID: 1775676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.